MAGI-3 regulates LPA-induced activation of Erk and RhoA
- 28 February 2007
- journal article
- Published by Elsevier BV in Cellular Signalling
- Vol. 19 (2), 261-268
- https://doi.org/10.1016/j.cellsig.2006.06.008
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancerLaboratory Investigation, 2004
- Thrombin and Lysophosphatidic Acid Receptors Utilize Distinct rhoGEFs in Prostate Cancer CellsPublished by Elsevier BV ,2004
- MAGI-3 is involved in the regulation of the JNK signaling pathway as a scaffold protein for frizzled and LtapOncogene, 2004
- NHERF2 Specifically Interacts with LPA2 Receptor and Defines the Specificity and Efficiency of Receptor-Mediated Phospholipase C-β3 ActivationMolecular and Cellular Biology, 2004
- TRIP6 Enhances Lysophosphatidic Acid-induced Cell Migration by Interacting with the Lysophosphatidic Acid 2 ReceptorPublished by Elsevier BV ,2004
- Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2)Oncogene, 2004
- Receptor-dependent RhoA Activation in G12/G13-deficient CellsPublished by Elsevier BV ,2003
- Molecular mechanisms of lysophosphatidic acid actionProgress in Lipid Research, 2003
- Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg FamilyPublished by Elsevier BV ,2003
- Recognition of Unique Carboxyl-Terminal Motifs by Distinct PDZ DomainsScience, 1997